Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Dublin City Schools is officially withdrawing from an agreement with Cardinal Health to purchase a vacant office building.

Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $129.68, which the company achieved on January ...

Cardinal Health (CAH) ended the recent trading session at $124.71, demonstrating a +0.55% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1 ...

Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments – Pharmaceutical and ...

He has covered insurance for a decade, including auto, home, life and health. Before cove... Amy Danise is the managing editor for the insurance section at Forbes Advisor, which encompasses auto ...

TD Cowen upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $144, up from $130. The firm believes new customers, strong utilization trends, and recent acquisitions into ...

He has covered insurance for a decade, including auto, home, life and health. Before cove... Amy Danise is the managing editor for the insurance section at Forbes Advisor, which encompasses auto ...

I'm PCMag's managing editor for consumer electronics, overseeing an experienced team of analysts covering smart home, home entertainment, wearables, fitness and health tech, and various other ...

2024 was packed with health care innovations, from a new blood test detecting Alzheimer’s disease to deep brain stimulation reversing paralysis. Heading into the New Year, medical experts are ...